Singapore Labs Get a Boost: ZeptoMetrix Launches Cutting-Edge H5N1 Control Using PLP Technology
Strengthening Singapore's Pandemic Preparedness: ZeptoMetrix Introduces Advanced H5N1 Control
BUFFALO, NEW YORK – June 23, 2025 – ZeptoMetrix®, a leader in molecular diagnostic quality assurance, is excited to announce the availability of NATtrol™ Influenza A H5N1 Quantitative Stock, a significant leap forward in ensuring the accuracy and reliability of influenza testing, particularly crucial for Singapore's ongoing pandemic preparedness efforts.
The H5N1 strain, a particularly virulent form of avian influenza, poses a constant threat globally. Rapid and accurate detection is paramount to containing outbreaks and protecting public health. Singapore, with its robust healthcare infrastructure and commitment to proactive health measures, is keenly focused on maintaining the highest standards of diagnostic testing.
What Makes This New Control Stock So Special? Phage-Like Particle (PLP) Technology
ZeptoMetrix’s NATtrol™ H5N1 Quantitative Stock utilizes groundbreaking Phage-Like Particle (PLP) technology. This isn't your typical control material. PLPs are engineered particles that mimic viruses, offering several key advantages:
- Enhanced Stability: PLPs are remarkably stable, ensuring consistent performance and a longer shelf life compared to traditional controls.
- Accurate Quantification: The 'Quantitative' in NATtrol™ H5N1 signifies the ability to precisely measure viral load, providing a more detailed and reliable assessment of test performance. This is vital for labs performing quantitative PCR (qPCR) assays.
- Broad Compatibility: This control stock is designed to be compatible with a wide range of commercially available H5N1 diagnostic assays used in Singaporean laboratories.
Why is Quality Assurance So Critical in Diagnostic Testing?
Molecular diagnostic testing, like PCR, is incredibly powerful but also susceptible to errors. Quality control measures are essential to:
- Detect Errors: Identify issues with reagents, equipment, or operator technique.
- Ensure Accuracy: Guarantee that test results are reliable and reflect the true presence or absence of the virus.
- Maintain Compliance: Meet regulatory requirements and accreditation standards.
The NATtrol™ Influenza A H5N1 Quantitative Stock provides laboratories in Singapore with a robust tool to validate their H5N1 testing processes, ultimately contributing to improved patient care and a stronger public health response.
Looking Ahead: ZeptoMetrix's Commitment to Diagnostic Excellence
ZeptoMetrix remains dedicated to developing innovative solutions that enhance the accuracy and reliability of molecular diagnostics worldwide. The launch of this new H5N1 control stock underscores that commitment, particularly to supporting nations like Singapore that prioritize proactive health security.
Learn more about NATtrol™ Influenza A H5N1 Quantitative Stock and ZeptoMetrix’s full range of quality control solutions at [ZeptoMetrix Website Link].
